Literature DB >> 23187945

An empiric risk scoring tool for identifying high-risk heterosexual HIV-1-serodiscordant couples for targeted HIV-1 prevention.

Erin M Kahle1, James P Hughes, Jairam R Lingappa, Grace John-Stewart, Connie Celum, Edith Nakku-Joloba, Stella Njuguna, Nelly Mugo, Elizabeth Bukusi, Rachel Manongi, Jared M Baeten.   

Abstract

BACKGROUND AND OBJECTIVES: Heterosexual HIV-1-serodiscordant couples are increasingly recognized as an important source of new HIV-1 infections in sub-Saharan Africa. A simple risk assessment tool could be useful for identifying couples at highest risk for HIV-1 transmission.
METHODS: Using data from 3 prospective studies of HIV-1-serodiscordant couples from 7 African countries and standard methods for development of clinical prediction rules, the authors derived and validated a risk scoring tool developed from multivariate modeling and composed of key predictors for HIV-1 risk that could be measured in standard research and clinical settings.
RESULTS: The final risk score included age of the HIV-1-uninfected partner, married and/or cohabiting partnership, number of children, unprotected sex, uncircumcised male HIV-1-uninfected partner, and plasma HIV-1 RNA in the HIV-1-infected partner. The maximum risk score was 12, scores ≥5 were associated with an annual HIV-1 incidence of >3%, and couples with a score ≥6 accounted for only 28% of the population but 67% of HIV-1 transmissions. The area under the curve for predictive ability of the score was 0.74 (95% confidence interval: 0.70 to 0.78). Internal and external validation showed similar predictive ability of the risk score, even when plasma viral load was excluded from the risk score.
CONCLUSIONS: A discrete combination of clinical and behavioral characteristics defines highest risk HIV-1-serodiscordant couples. Discriminating highest risk couples for HIV-1 prevention programs and clinical trials using a validated risk score could improve research efficiency and maximize the impact of prevention strategies for reducing HIV-1 transmission.

Entities:  

Mesh:

Year:  2013        PMID: 23187945      PMCID: PMC3620695          DOI: 10.1097/QAI.0b013e31827e622d

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  41 in total

1.  Interim guidance: preexposure prophylaxis for the prevention of HIV infection in men who have sex with men.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-01-28       Impact factor: 17.586

2.  The Evolving Role of HIV Counseling and Testing in Resource-limited Settings: HIV Prevention and Linkage to Expanding HIV Care Access.

Authors:  Cheryl A Liechty
Journal:  Curr Infect Dis Rep       Date:  2005-03       Impact factor: 3.725

3.  Sexual behavior of HIV discordant couples after HIV counseling and testing.

Authors:  Susan Allen; Jareen Meinzen-Derr; Michele Kautzman; Isaac Zulu; Stanley Trask; Ulgen Fideli; Rosemary Musonda; Francis Kasolo; Feng Gao; Alan Haworth
Journal:  AIDS       Date:  2003-03-28       Impact factor: 4.177

Review 4.  Clinical prediction rules. A review and suggested modifications of methodological standards.

Authors:  A Laupacis; N Sekar; I G Stiell
Journal:  JAMA       Date:  1997-02-12       Impact factor: 56.272

5.  Pregnancy and HIV transmission among HIV-discordant couples in a clinical trial in Kisumu, Kenya.

Authors:  S G Brubaker; E A Bukusi; J Odoyo; J Achando; A Okumu; C R Cohen
Journal:  HIV Med       Date:  2010-10-14       Impact factor: 3.180

6.  A prospective study of contraceptive use among African women in HIV-1 serodiscordant partnerships.

Authors:  Renee Heffron; Edwin Were; Connie Celum; Nelly Mugo; Kenneth Ngure; James Kiarie; Jared M Baeten
Journal:  Sex Transm Dis       Date:  2010-10       Impact factor: 2.830

7.  Sexual risk behaviors among HIV-infected South African men and women with their partners in a primary care program: implications for couples-based prevention.

Authors:  Kartik K Venkatesh; Guy de Bruyn; Mark N Lurie; Tebogo Modisenyane; Elizabeth W Triche; Glenda E Gray; Alex Welte; Neil A Martinson
Journal:  AIDS Behav       Date:  2012-01

8.  Fertility desires and condom use among HIV-positive women at an antiretroviral roll-out program in Zimbabwe.

Authors:  M Kathryn McClellan; Rena Patel; Gerard Kadzirange; Tsungai Chipatod; David Katzenstein
Journal:  Afr J Reprod Health       Date:  2010-06

9.  New heterosexually transmitted HIV infections in married or cohabiting couples in urban Zambia and Rwanda: an analysis of survey and clinical data.

Authors:  Kristin L Dunkle; Rob Stephenson; Etienne Karita; Elwyn Chomba; Kayitesi Kayitenkore; Cheswa Vwalika; Lauren Greenberg; Susan Allen
Journal:  Lancet       Date:  2008-06-28       Impact factor: 79.321

Review 10.  HIV epidemiology update and transmission factors: risks and risk contexts--16th International AIDS Conference epidemiology plenary.

Authors:  Chris Beyrer
Journal:  Clin Infect Dis       Date:  2007-02-26       Impact factor: 9.079

View more
  78 in total

1.  Regulatory T-Cell Activity But Not Conventional HIV-Specific T-Cell Responses Are Associated With Protection From HIV-1 Infection.

Authors:  Laura Pattacini; Jared M Baeten; Katherine K Thomas; Tayler R Fluharty; Pamela M Murnane; Deborah Donnell; Elizabeth Bukusi; Allan Ronald; Nelly Mugo; Jairam R Lingappa; Connie Celum; M Juliana McElrath; Jennifer M Lund
Journal:  J Acquir Immune Defic Syndr       Date:  2016-06-01       Impact factor: 3.731

Review 2.  Weighing the Evidence of Efficacy of Oral PrEP for HIV Prevention in Women in Southern Africa.

Authors:  Holly Janes; Lawrence Corey; Gita Ramjee; Lindsay N Carpp; Carl Lombard; Myron S Cohen; Peter B Gilbert; Glenda E Gray
Journal:  AIDS Res Hum Retroviruses       Date:  2018-06-19       Impact factor: 2.205

3.  Concordance of self-reported hormonal contraceptive use and presence of exogenous hormones in serum among African women.

Authors:  Maria Pyra; Jairam R Lingappa; Renee Heffron; David W Erikson; Steven W Blue; Rena C Patel; Kavita Nanda; Helen Rees; Nelly R Mugo; Nicole L Davis; Athena P Kourtis; Jared M Baeten
Journal:  Contraception       Date:  2018-02-17       Impact factor: 3.375

4.  Perceived Risk Among Human Immunodeficiency Virus Serodiscordant Couples in East Africa Taking Oral Pre-Exposure Prophylaxis.

Authors:  Jennifer J Carroll; Renee Heffron; Nelly Mugo; Kenneth Ngure; Patrick Ndase; Stephen Asiimwe; Connie Celum; Jared M Baeten
Journal:  Sex Transm Dis       Date:  2016-08       Impact factor: 2.830

Review 5.  Advances in HIV prevention for serodiscordant couples.

Authors:  Kathryn E Muessig; Myron S Cohen
Journal:  Curr HIV/AIDS Rep       Date:  2014-12       Impact factor: 5.071

6.  HIV risk associated with serum medroxyprogesterone acetate levels among women in East and southern Africa.

Authors:  Renee Heffron; Randy Stalter; Maria Pyra; Kavita Nanda; David W Erikson; Florian Hladik; Steven W Blue; Nicole L Davis; Nelly Mugo; Athena P Kourtis; Jairam R Lingappa; Jared M Baeten
Journal:  AIDS       Date:  2019-03-15       Impact factor: 4.177

7.  Perceived Versus Calculated HIV Risk: Implications for Pre-exposure Prophylaxis Uptake in a Randomized Trial of Men Who Have Sex With Men.

Authors:  Jill Blumenthal; Sonia Jain; Evan Mulvihill; Shelly Sun; Marvin Hanashiro; Eric Ellorin; Sara Graber; Richard Haubrich; Sheldon Morris
Journal:  J Acquir Immune Defic Syndr       Date:  2019-02-01       Impact factor: 3.731

8.  Measuring HIV Risk Perception and Behavior: Results from Round 1 of the Cognitive Interviewing Project with young women and men who have sex with men in South Africa.

Authors:  Jessica Milne; Hannah Brady; Thembekile Shato; Danielle Bohn; Makhosazana Mdladla; Nangamso Ngcwayi; Millicent Atujuna; Hilton Humphries; K Rivet Amico
Journal:  AIDS Behav       Date:  2020-08

Review 9.  Initiation, discontinuation, and restarting HIV pre-exposure prophylaxis: ongoing implementation strategies.

Authors:  Sarah E Rutstein; Dawn K Smith; Shona Dalal; Rachel C Baggaley; Myron S Cohen
Journal:  Lancet HIV       Date:  2020-08-27       Impact factor: 12.767

Review 10.  The preexposure prophylaxis revolution; from clinical trials to programmatic implementation.

Authors:  Nelly R Mugo; Kenneth Ngure; Michael Kiragu; Elizabeth Irungu; Nduku Kilonzo
Journal:  Curr Opin HIV AIDS       Date:  2016-01       Impact factor: 4.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.